Your browser doesn't support javascript.
loading
[Efficacy and safety of lenalidomide combined with bortezomib and dexamethasone induction therapy in newly diagnosed patients with multiple myeloma].
Yao, W Q; Yan, L Z; Shang, J J; Jin, S; Shi, X L; Yan, S; Yan, Z; Wang, Q Q; Fu, C C; Wu, D P.
Afiliação
  • Yao WQ; The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215000, China.
  • Yan LZ; The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215000, China.
  • Shang JJ; The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215000, China.
  • Jin S; The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215000, China.
  • Shi XL; The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215000, China.
  • Yan S; The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215000, China.
  • Yan Z; The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215000, China.
  • Wang QQ; The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215000, China.
  • Fu CC; The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215000, China.
  • Wu DP; The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou 215000, China.
Zhonghua Xue Ye Xue Za Zhi ; 43(8): 657-662, 2022 Aug 14.
Article em Zh | MEDLINE | ID: mdl-36709150

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Mieloma Múltiplo / Neutropenia Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Trombocitopenia / Mieloma Múltiplo / Neutropenia Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: Zh Revista: Zhonghua Xue Ye Xue Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China